SciELO - Scientific Electronic Library Online

 
vol.110 número4Hemorragia digestiva grave de origen oscuro resuelta con idarucizumabMigración tardía de prótesis tras drenaje ecoendoscópico de pseudoquiste pancreático abscesificado índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista Española de Enfermedades Digestivas

versión impresa ISSN 1130-0108

Rev. esp. enferm. dig. vol.110 no.4 Madrid abr. 2018

https://dx.doi.org/10.17235/reed.2018.5415/2017 

LETTERS TO THE EDITOR

Author's reply: Cystic pancreatic neuroendocrine tumors. A diagnostic challenge

Javier-A. Cienfuegos1  , Luis Hurtado-Pardo1  , Javier Antoñanzas1 

1Departamento de Cirugía General. Clínica Universidad de Navarra. Pamplona, España

Key words:  Cystic pancreatic neuroendocrine tumors; Phenotype; Incidental

Dear Editor,

We are grateful for the helpful comments of Varas et al. 1 with regard to the phenotype of cystic pancreatic neuroendocrine tumors (CPNT) reported in a recent meta-analysis of 436 patients 2.

Varas et al. highlight the lower incidence of CPNT diagnosed incidentally in 135 patients (44.6%) in comparison with a recent series of 49 patients with an incidental tumor diagnosis of 56.5% 3.

The reason why the percentage of incidental tumors was lower in our analysis is due to the fact that the study was based on all resected cases between 1945 and September 2016. Since 2000, there has been an increased use of more sensitive diagnostic techniques such as computerized axial tomography, nuclear magnetic resonance imaging and ultrasound endoscopy. This has resulted in a considerable increase in the number of tumors incidentally diagnosed (incidentalomas), with figures reaching 80% in some studies and representing 50% of pancreatic surgeon consultations. These issues are discussed within the discussion section of the meta-analysis 2. Before 2000, most CPNT were diagnosed on the basis of digestive symptoms and, logically, were larger in size 4.

Furthermore, the phenotype and biological behavior described in our meta-analysis are very similar to those of the 49 cases reported by Paiella 3. These comments reflect the significant increase (4.6 fold) in the prevalence and accumulated incidence of gastrointestinal neuroendocrine tumors, from 1.09/100,000 in 1973 to 6.98/100,000 inhabitants in 2012 5. Nowadays, they have overtaken the incidence of esophageal, gastric and pancreatic cancers. Due to their indolent presentation and frequent incidental diagnosis, these tumors represent a particular challenge for gastroenterologists.

Bibliografía

1. Varas M, Loras C, Balboa A. Cystic neuroendocrine tumors of the pancreas. Rev Esp Enferm Dig 2018. En prensa. [ Links ]

2. Hurtado-Pardo L, A Cienfuegos J, Ruiz-Canela M, et al. Cystic pancreatic neuroendocrine tumors (cPNETs): a systematic review and meta-analysis of case series. Rev Esp Enferm Dig 2017;109(11):778-87. DOI: 10.17235/reed.2017.5044/2017 [ Links ]

3. Paiella S, Marchegiani G, Miotto M, et al. Are cystic pancreatic neuroendocrine tumors an indolent entity? Results from a single center surgical series. Neuroendocrinology 2017. E-pub ahead of print. DOI: 10.1159/000477849 [ Links ]

4. Cienfuegos JA, Rotellar F, Salguero J, et al. A single institution's 21-year experience with surgically resected pancreatic neuroendocrine tumors: an analysis of survival and prognostic factors. Rev Esp Enferm Dig 2016;108(11):689-96. [ Links ]

5. Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 2017;3(10):1335-42. DOI: 10.1001/jamaoncol.2017.0589 [ Links ]